Share Name Share Symbol Market Type Share ISIN Share Description
Angle Plc LSE:AGL London Ordinary Share GB0034330679 ORD 10P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +0.50p +0.95% 53.00p 52.00p 54.00p 53.00p 52.50p 52.50p 43,282.00 08:07:08
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Support Services 0.4 -5.4 -8.6 - 39.65

Angle Share Discussion Threads

Showing 44951 to 44975 of 44975 messages
Chat Pages: 1799  1798  1797  1796  1795  1794  1793  1792  1791  1790  1789  1788  Older
DateSubjectAuthorDiscuss
26/4/2017
19:27
On the website 2, but seems to be ctDNA Https://www.theguardian.com/society/2017/apr/26/dna-based-test-can-spot-cancer-recurrence-a-year-before-conventional-scans Http://www.bbc.co.uk/news/health-39658680 Http://www.dailymail.co.uk/wires/ap/article-4448666/Blood-tests-track-lung-cancer-gene-changes-aiding-treatment.html?ITO=1490&ns_mchannel=rss&ns_campaign=1490
banshee
26/4/2017
18:28
Lung cancer blood test, just been on BBC news
anderson3
26/4/2017
15:25
There is a big fire at the Christie Cancer Research Centre, just the sort of black swan event that can badly hit any research project.
clausentum
25/4/2017
21:39
Willfy - the video seems to be referring to CTDNA not CTC's
johnski_uk
25/4/2017
17:46
Worth having a look at on twitter, from cancer research ukBlood tests that analyse tumour DNA are showing promise for monitoring how cancer patients respond to treatment #DNADay17End of the video says liquid biopsy , so may well be Parsortix
willfy
25/4/2017
11:11
Looking like some decent volume building now. Hoping this is the start of a re-rate before the results.
maxie23
25/4/2017
07:56
That 65p level just so happens to be around the old 64.5p placing. Once that goes...
boris cobaka
24/4/2017
19:35
Cant be long now until this realises its true potential.
smoothride
24/4/2017
16:45
But don't take too long, the trial results could be out tomorrow :) Https://www.genomeweb.com/sequencing/ovarian-cancer-genomic-analysis-reveals-seven-disease-stratifying-clusters?utm_source=Sailthru&utm_medium=email&utm_campaign=GWDN%20Mon%20PM%202017-04-24&utm_term=GW%20Daily%20News%20Bulletin
banshee
24/4/2017
10:38
Crack on son, fill your boots.
oiht
21/4/2017
19:55
Taking a position here early next week. The story is good and technically there's a very impressive divergence that is apparent both on the daily and weekly chart. It's viewable on both rsi and macd. Together with a massive volume week (biggest for almost 2 years) it's ripe for a decent bounce. Since topping in May 2015 it's not actually approached overbought on a number of indicators which in itself is quite remarkable. That last low was engineered imo to snare a few stops - it's the lowest the share price has been since May 2013. The bounce out of that was very strong - the sp's taking a bit of a breather but I doubt it'll hang around for too long. 65p is the biggie. A close above that and I suspect this could regain 1.00 quite quickly. The catalyst for much of the above will very likely be the impending news but I could see some buying in advance so as usual keep an eye on the volume. Gl.
boris cobaka
20/4/2017
19:24
There seem to be quite a few references to Parsortix at moleculardxeurope.com which was on 10-13 April 2017 in Lisbon. I thought some of these may have come up on Twitter.
semper vigilans
20/4/2017
11:47
We live in hope, Semper.
jelenko
20/4/2017
09:57
Can't be far off test results release. Also, those who were tested could be further assisted by follow-on tests?
semper vigilans
13/4/2017
14:12
Might even have a blue finish. Have a good holiday weekend all.
maxie23
13/4/2017
07:00
Good idea wells, but having read the BBC article, it seems a relatively small unit if they are only putting forward six people per day. I hope that they have plans to increase the scale. Perhaps cost constraints would mean that the drug costs resulting from more rapid diagnosis of a higher volume of patients would put a dampener on it. Easter shutdown has started!
semper vigilans
12/4/2017
17:47
A one stop shop for cancer diagnosis is being set up in cynon valley south wales. An opportunity for Angle?
wells777
12/4/2017
12:24
ANGLE plc (AIM: AGL OTCQX: ANPCY), the specialist medtech company with pioneering products for cancer diagnostics, is pleased to announce the appointment of Daniel Costin Danila, MD, as a Scientific Advisor to the Company with immediate effect.Dr Danila is a leader in the development and adoption of CTCs as predictive biomarkers to help clinicians select appropriate treatments.
eddiegoldstein
12/4/2017
12:14
I presume you know that he has been a scientific advisor to Angle since 2015.
jelenko
12/4/2017
10:52
Auphilman - I may be wrong,just that he seems to be a common denominator.
semper vigilans
12/4/2017
10:42
ah yes got him now.. well interesting point SV.. there is clearly work in the background we r never told.. take the Athens announcement..
auphilman
12/4/2017
10:34
Dr.Daniel Danila?
semper vigilans
11/4/2017
17:26
www.sohnconference.org/wp-content/uploads/2017/03/WeillCornellDavidLydenMSK_PressRelease.pdf I dont recognise any of the names or institutions SV, but then there is no info i have found of how they intend to structure the research.
auphilman
11/4/2017
16:16
Anyone know if collaboration between Weill Cornell and Kettering Sloane on liquid biopsy has anything to do with AGL please?
semper vigilans
11/4/2017
10:29
Morning all. No volume at the mo. I wondered if we'd see a pick up as some buy in in preparation for the results. Still plenty of time I guess.
boris cobaka
Chat Pages: 1799  1798  1797  1796  1795  1794  1793  1792  1791  1790  1789  1788  Older
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:41 V: D:20170427 05:08:02